The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers

Journal of Urology

Volumn 155, Issue 2, 1996, Pages 587-589

  Saxman, Scott B ^a   Nichols, Craig R ^a   Foster, Richard S ^a   Messemer, Jonathan E ^a   Donohue, John P ^a   Einhorn, Lawrence H ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

lymph node excision; retroperitoneal neoplasms; testicular neoplasms; tumor markers, biological

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; CHORIONIC GONADOTROPIN; TESTOSTERONE; TUMOR MARKER;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; EMBRYONAL CARCINOMA; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; NON SEMINOMATOUS GERMINOMA; ORCHIECTOMY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SEMINOMA; SEROLOGY; TERATOMA;

EID: 0030051371     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66457-7     Document Type: Article

References (7)

1. Donohue, J. P., Thornhill, J. A., Foster, R. S., Rowland, R. G. and Bihrle, R.: Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): modifications of technique and impact on ejaculation. J. Urol., 149: 237, 1993.
2. Davis, B. E., Herr, H. W., Fair, W. R. and Bosl, G. J.: The management of patients with nonseminomatous germ cell tumors of the testis with serologic disease only after orchiectomy. J. Urol., 152: 111, 1994.
3. Einhorn, L. H., Richie, J. P. and Shipley, W. U.: Cancer of the testis. In: Cancer: Principles and Practice of Oncology, 4th ed. Edited by V. T. DeVita, S. Hellman and S. A. Rosenberg. Philadelphia: J. B. Lippincott Co., p. 1130, 1993.
4. Bosl, G. J., Geller, N. L., Cirrincione, C., Nisselbaum, J., Vugrin, D., Whitmore, W. F., Jr. and Golbey, R. B.: Serum tumor markers in patients with metastatic germ cell tumors of the testis. A 10-year experience. Amer. J. Med., 75: 29, 1983.
5. Phillips, M. I., Weiner, R., MacLaren, N. and Kappy, M.: Test of false-positive testicular cancer marker by suppressing luteinizing hormone with testosterone. Lancet, 2: 928, 1982.
6. Loehrer, P. J., Eisenhut, C. and Sample, M.: How to cope with antibodies to HCG in laboratory testing. J. Clin. Ligand Assay Soc., 10: 58, 1987.
7. Read, G., Stenning, S. P., Cullen, M. H., Parkinson, M. C., Horwich, A., Kaye, S. B. and Cook, P. A.: Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party. J. Clin. Oncol., 10: 1762, 1992.